GB8829088D0 — Compounds
Assigned to Smith Kline and French Laboratories Ltd · Expires 1989-01-25 · 37y expired
What this patent protects
Polymers of structure: <CHEM> in which X is a cross-linking unit, X<1> is a comonomer unit, R<1> is hydrogen or C1-4alkyl and R<1> and R<2> are the same or different and are each C1-2alkyl or aralkyl, or R<1> to R<3> together form a ring,…
USPTO Abstract
Polymers of structure: <CHEM> in which X is a cross-linking unit, X<1> is a comonomer unit, R<1> is hydrogen or C1-4alkyl and R<1> and R<2> are the same or different and are each C1-2alkyl or aralkyl, or R<1> to R<3> together form a ring, compositions containing them and their use in therapy for the lowering of serum cholesterol levels.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.